| Typicality: | 0.353 |
| Saliency: | 0.241 |
| with a chemotherapeutic agent | 4 | other |
| with cyclophosphamide | 4 | other |
| with antisense oligonucleotides | 4 | other |
| compound → be administered in → combination | 10 |
| negative | neutral | positive |
| 0.051 | 0.844 | 0.104 |
| Raw frequency | 10 |
| Normalized frequency | 0.241 |
| Modifier score | 0.500 |
| Perplexity | 470.108 |